The debt of MBX Biosciences, Inc. over the past 3 years
Chart MBX Biosciences, Inc.: liquid cash, total debt, net cash, fiscal 2023–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, MBX Biosciences, Inc. had liquid cash of $373.7M and total debt of $0: net cash of $373.7M. It had more liquid cash than debt at all 3 year-ends shown.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $373.7M* | $0 | $373.7M |
| 2024ended Dec 31, 2024 | $262.15M* | $0 | $262.15M |
| 2023ended Dec 31, 2023 | $80.68M* | $0 | $80.68M |
Fiscal years as MBX Biosciences, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on MBX Biosciences, Inc.
- The profitability of MBX Biosciences, Inc.
- The cash flow of MBX Biosciences, Inc.
- All of MBX Biosciences, Inc.'s financials, charted
Companies of a similar size
- LBTYALiberty Global Ltd.
- GPKGraphic Packaging Holding Co
- BFAMBRIGHT HORIZONS FAMILY SOLUTIONS INC.
- PATKPATRICK INDUSTRIES INC
- DXDYNEX CAPITAL, INC.
Not investment advice. This page shows what MBX Biosciences, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.